We are monitoring the impact of COVID-19 on Europe EXMO Machine Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4799
Share on
Share on

Europe ECMO Machine Market Research Report – By Modality, Application & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Trends & Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 4799
Pages: 145

Europe ECMO Machine Market Size (2020 to 2025)

According to the report, the Europe ECMO Machine Market size is forecasted to grow USD 83.34 billion by 2025 from USD 67.23 million in 2020, registering a CAGR of 4.39% between 2020 to 2025. Europe accounts for the second-largest share of the market. The favorable reimbursement scenario, rising incidence of lung cancer, and the presence of a large number of ECMO centers are expected to boost the market.

The rising number of people affected by respiratory problems like pulmonary hypertension, respiratory failure, respiratory distress syndrome, and meconium aspiration syndrome, and cardiovascular diseases propels the market growth. According to data reported by Eurostat, approximately 61% of women and 45% of men in Estonia lost their lives because of cardiovascular diseases in 2014. Nearly 312,000 people in Europe are diagnosed with lung cancer, according to Luce Report on Lung Cancer 2016. 85million people and above live with cardiovascular diseases in Europe in 2015, as per the European Cardiovascular Disease Statistics.

Strict guidelines for the approval of medical devices may hinder the market growth of the region. For example, in Estonia, manufacturers need CE mark approval to commodify each of the medical devices. The scarcity of expert professionals and the cost associated with the treatment procedures is so expensive that they are hampering the region's ECMO market growth. Moreover, obstacles related to the treatment in real-time like bleeding, infections, and failure of the devices are likely to restrain the ECMO machine market growth in Europe.

This research report on the Europe Extracorporeal Membrane Oxygenation Machine Market has been segmented and sub-segmented into the following categories

  • By Modality: Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV).
  • By Application: Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR).
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe.

Regional Analysis:

Europe accounts for the second-largest share of the market. The factors attributed to the market growth are the existence of many extracorporeal membrane oxygenation machine centers and acceptable reimbursement policies. Nearly 6.5 million people are affected by respiratory diseases, according to Eurostat, in 2013. UK is on top of ruling the ECMO market in the region. The presence of well-established healthcare infrastructure, rise in chronic diseases like cardiac and respiratory diseases caused by lifestyle changes and diet habits, and key players' participation with different strategies is to escalate the market in the region. The UK follows Germany in leading the market because of the growing aging population; key players are launching new products and strategic collaborations in establishing the market in the region. The European government has taken several measures to enlarge the usage propelling of the extracorporeal membrane oxygenation machine market.

Prominent Companies dominating the Europe Extracorporeal Membrane Oxygenation Machine Market Profiled in the Report are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc., ALung Technologies Inc., and EUROSETS S.r.l.

1.Introduction               

                1.1 Market Definition 

                1.2 Study Deliverables 

                1.3 Base Currency, Base Year and Forecast Periods       

                1.4 General Study Assumptions

2. Research Methodology                        

                2.1 Introduction            

                2.2 Research Phases   

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design      

                2.4 Study Timeline       

3. Overview                    

                3.1 Executive Summary

                3.2 Key Inferences      

                3.3 Epidemiology           

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                 

                4.1 Market Drivers       

                4.2 Market Restraints 

                4.3 Key Challenges      

                4.4 Current Opportunities in the Market           

5. Market Segmentation                           

                5.1 Modality   

                                5.1.1 Introduction                                                           

                                5.1.2 Venovenous ECMO                                                             

                                5.1.3 Venoarterial ECMO                                                             

                                5.1.4 Arteriovenous ECMO                                                         

                                5.1.5  Y-o-Y Growth Analysis, By Modality                                                            

                                5.1.6  Market Attractiveness Analysis, By Modality                                                          

                                5.1.7  Market Share Analysis, By Modality                                                            

                5.2 Application

                                5.2.1 Introduction                                                           

                                5.2.2 Respiratory Applications                                                   

                                                5.2.2.1 Neonates                                             

                                                5.2.2.2 Pediatrics                                             

                                                5.2.2.3 Adults                                    

                                5.2.3 Cardiac Applications                                                            

                                                5.2.3.1 Neonates                                             

                                                5.2.3.2 Pediatrics                                             

                                                5.2.3.3 Adults                                    

                                5.2.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)                                                        

                                                5.2.4.1 Neonates                                             

                                                5.2.4.2 Pediatrics                                             

                                                5.2.4.3 Adults                                    

                                5.2.5 Y-o-Y Growth Analysis, By Application                                                         

                                5.2.6 Market Attractiveness Analysis, By Application                                                       

                                5.2.7 Market Share Analysis, By Application                                                        

6. Geographical Analysis                           

                6.1 Introduction            

                                6.1.1 Regional Trends                                                    

                                6.1.2 Impact Analysis                                                     

                                6.1.3 Y-o-Y Growth Analysis                                                        

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By Modality                                         

                                                6.1.3.3 By Application                                    

                                6.1.4  Market Attractiveness Analysis                                                     

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By Application                                    

                                                6.1.4.3 By Type                                 

                                6.1.5  Market Share Analysis                                                      

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By Modality                                         

                                                6.1.5.3 By Application                                    

                6.2 U.K

                6.3 Spain          

                6.4 Germany  

                6.5 Italy            

                6.6 France       

               6.7 Rest of Europe

7.Strategic Analysis                     

                7.1 PESTLE analysis      

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis           

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8.Market Leaders' Analysis                      

                8.1 Getinge Group       

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments                                                       

                                8.1.5 SWOT analysis                                                       

                                8.1.6 Analyst View                                                          

                8.2 Medtronic plc         

                8.3 LivaNova PLC          

                8.4 XENIOS AG

                8.5 Terumo Corporation            

                8.6 MicroPort Scientific Corporation    

                8.7 NIPRO Corporation

                8.8 OriGen Biomedical Inc.       

                8.9 ALung Technologies Inc.    

                8.10 EUROSETS S.r.l.    

9.Competitive Landscape                         

                9.1 Market share analysis         

                9.2 Merger and Acquisition Analysis    

                9.3 Agreements, Collaborations, and Joint Ventures      

                9.4 New Product Launches      

10.Market Outlook and Investment Opportunities                       

Appendix                        

                a) List of Tables

                b) List of Figures           

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Modality and Application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Europe Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensivePESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2020-2025 ( USD Million )
  2. Europe Veno-Arterial (VA) Market By Region, From 2020-2025 ( USD Million )
  3. Europe Veno-Venous (VV) Market By Region, From 2020-2025 ( USD Million )
  4. Europe Arterio-Venous (AV) Market By Region, From 2020-2025 ( USD Million )
  5. Europe Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2020-2025 ( USD Million )
  6. Europe Respiratory Market By Region, From 2020-2025 ( USD Million )
  7. Europe Cardiac Market By Region, From 2020-2025 ( USD Million )
  8. Europe Extracorporeal Cardiopulmonary Resuscitation (ECPR)) Market By Region, From 2020-2025 ( USD Million )
  9. U.K. Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2020-2025 ( USD Million )
  10. U.K. Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2020-2025 ( USD Million )
  11. Germany Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2020-2025 ( USD Million )
  12. Germany Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2020-2025 ( USD Million )
  13. France Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2020-2025 ( USD Million )
  14. France Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2020-2025 ( USD Million )
  15. Italy Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2020-2025 ( USD Million )
  16. Italy Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2020-2025 ( USD Million )
  17. Spain Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2020-2025 ( USD Million )
  18. Spain Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2020-2025 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample